• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

ALR Technologies inks Indian marketing deal for diabetes management device

August 29, 2018 By Sarah Faulkner

ALR TechnologiesALR Technologies and Aspire Cerebro Advertising have inked a marketing deal in India for the ALRT diabetes management system.

Aspira Cerebro Advertising plans to create a comprehensive marketing plan for the ALRT Diabetes Solution system, with the intent of bringing the technology to India’s estimated 100 million diabetes patients.

“Our model enables pharmaceutical companies to provide the ALRT Diabetes Solution to health clinics and simplify delivery of best-practice diabetes care.  This will increase the efficiency of the clinics, and improve health outcomes for patients suffering from diabetes in India,” ALR chairman & CEO Sidney Chan said in prepared remarks.

“We are excited to launch ALRT in India. They have technology to improve patient outcomes,” Amit Bhagchandani, founder & mentor of Aspire Cerebro, added. “To bring the best of healthcare solutions to India, ALRT Technologies empowers our mission of inspiring healthier lives.”

“ALRT Diabetes Solution will make a significant difference in lives of diabetes patients. We immediately recognized the value it could bring to patients, HCPs and our clients,” Sanjeev Chopra, CEO of Aspire Cerebro said. “We are looking forward to introducing ALRT to Indian markets.”

ALR’s ALRT system combines data from blood glucose meters with an FDA-approved insulin dosing adjustment feature that suggests insulin dosing changes. The company’s system also includes performance tracking features to monitor treatment success in between visits to the doctor.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Alrtechnologies

IN CASE YOU MISSED IT

  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China
  • Convatec wins FDA approval for Parkinson’s treatment infusion tech

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS